Loading...
OTCM
FRLI
Market cap0USD
May 14, Last price  
0.00USD
Name

Frelii Inc

Chart & performance

D1W1MN
OTCM:FRLI chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
00000229,159234,038000000035,9450000
Net income
0
-28,562-189,993-976,204-205,721-311,983160,404-362,356-2,210,164-271,358-246,812-269,545-274,029-270,988595,492-5,549,6780000
CFO
0
-27,367-31,121-396,193-107,522-45,257-194,438-158,761-39,196-44,961-18,154-21,690-15,811-5,831-37,064-910,1080000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Frélii, Inc. specializes in delivering personalized, subscription-based health and wellness programs. Through its frelii.com web platform, the company designs individual health assessments and tailored nutrition plans. These plans are meticulously developed by analyzing a comprehensive range of personal data, including genetic information, physiological markers, environmental influences, lifestyle choices, and diagnostic lab results. Additionally, the platform facilitates access to various related health products, such as diagnostic testing kits, custom-compounded pharmacy items, and a selection of nutritional and vitamin supplements. Formerly operating as Vican Resources, Inc., the organization rebranded to Frélii, Inc. in March 2018. The company maintains its headquarters in Lehi, Utah.

Key people

Ian Jenkins
Chief Executive Officer, Chief Financial Officer, Director · since 2017
Sandeep Uppal
Chief Administrative Officer · since 2019
Hans Jenkins
Director, Chief Medical Officer · since 2018
Leslie Norris
Director · since 2019
URL
IPO date
Jan 18, 2005
Employees
Domiciled in
US
Incorporated in
US
Legal address
C/O Registered Agents Inc.
401 Ryland Street
Suite 200-A
Reno, NV 89502
US
Headquarters
6600 Decarie Boulevard
Suite 220
Montreal, QC H3X 2K4
CA
Previous name
Bayview Corp
Previous name
Xpention Genetics Inc
Previous name
Tremont Fair, Inc.
Previous name
Cancer Detection Corp.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT